Last updated at 05 Jul 2024 05:11 AM
Director
DIN: 06378884
Birju Rajendra Shah is currently associated with 2 companies in various capacities such as Director and CFO. They serve as a Director at RESONANT PHARMACEUTICALS PRIVATE LIMITED and have other roles in different companies. They are registered with the Ministry of Corporate Affairs (MCA) of India and hold a DIN of 06378884.Birju Rajendra Shah has previously been associated with 3 companies in roles such as Director.Birju Rajendra Shah is currently involved in 2 different roles. Their most recent position is with R R SECURITIES LTD as a CFO. The first company Birju Rajendra Shah was appointed to as a director was RESONANT PHARMACEUTICALS PRIVATE LIMITED. Birju Rajendra Shah is not disqualified by the Registrar of Companies under Section 164(2), and their DIN has not been deactivated due to failure to file the DIR-3 KYC Form.
Birju Rajendra Shah is currently associated with 2 companies in various capacities such as Director and CFO. They serve as a Director at RESONANT PHARMACEUTICALS PRIVATE LIMITED and have other roles in different companies. They are registered with the Ministry of Corporate Affairs (MCA) of India and hold a DIN of 06378884.Birju Rajendra Shah has previously been associated with 3 companies in roles such as Director.Birju Rajendra Shah is currently involved in 2 different roles. Their most recent position is with R R SECURITIES LTD as a CFO. The first company Birju Rajendra Shah was appointed to as a director was RESONANT PHARMACEUTICALS PRIVATE LIMITED. Birju Rajendra Shah is not disqualified by the Registrar of Companies under Section 164(2), and their DIN has not been deactivated due to failure to file the DIR-3 KYC Form.
2
Male
India
Gain instant access to verified contact details.
Current Companies (2)
Current LLPs (0)
Past Companies (3)
3y 10m 1y 11m Interval
| Company Name | Designation | Date of Appointment |
|---|---|---|
| RESONANT PHARMACEUTICALS PRIVATE LIMITED | Director | 26-Nov-2014 |
| R R SECURITIES LTD | CFO | 30-Sep-2019 |